Submissions from 2023
Response to "Department of Commerce, National Institute of Standards and Technology, Agency Information Collection Activities", Fred D. Ledley
Tech Note 2023-1 NIH Contribution to Phased Clinical Development of Drugs Approved from 2010-2019, Edward Zhou, Matthew Jackson, and Fred Ledley
